The Coalition for Epidemic Preparedness Innovations, or CEPI, wants to raise at least $2.5 billion to support its work for the next five years.
Under a new strategy, called CEPI 3.0, the organization aims to continue and expand its work supporting the development of vaccines for known and emerging threats, ensure the technologies are available to rapidly develop these vaccines in the event of an outbreak, and that the capabilities are there to manufacture and deploy them within a 100-day window.
CEPI estimates it will need $3.6 billion to deliver the strategy. It has so far secured $1.1 billion, carried over from previous funding from its philanthropic backers such as the Gates Foundation and Wellcome for some of its existing vaccine programs, and early pledges from Germany.
About the author
Jenny Lei Ravelo@JennyLeiRavelo
Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
